Back to search

Article

Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector function

2025-10-27

Abstract excerpt

<title>Abstract</title> <p>Janus kinase inhibitors (JAKis) are widely prescribed for autoimmune diseases, but their use is associated with increased infection risk. The mechanisms underlying this susceptibility remain unclear. CD8 T cells play a central role in antimicrobial defense, yet little is known about how JAKis reprogram their activation and effector programs. Here, we investigated naïve and memory CD8 T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8dcaaca1-5a62-5661-8b09-5c54e2c5b09a
DOI
10.21203/rs.3.rs-7794494/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector functionDOI 10.21203/rs.3.rs-7794494/v1
Select a neighboring publication to make it the new centre.